High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arrays
Open accessAbstract
Methods to rapidly assess cell growth would be useful for many applications, including drug susceptibility testing, but current technologies have limited sensitivity or throughput. Here we present an approach to precisely and rapidly measure growth rates of many individual cells simultaneously. We flow cells in suspension through a microfluidic channel with 10-12 resonant mass sensors distributed along its length, weighing each cell repeatedly over the 4-20 min it spends in the channel. Because multiple cells traverse the channel at the same time, we obtain growth rates for >60 cells/h with a resolution of 0.2 pg/h for mammalian cells and 0.02 pg/h for bacteria. We measure the growth of single lymphocytic cells, mouse and human T cells, primary human leukemia cells, yeast, Escherichia coli and Enterococcus faecalis. Our system reveals subpopulations of cells with divergent growth kinetics and enables assessment of cellular responses to antibiotics and antimicrobial peptides within minutes.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A next-generation suspended microchannel resonator array device simplifies fluidic handling, increases throughput 20-fold, and enables low-volume samples.
“In order to measure samples of low cell count and volume, we implemented a next-generation SMR array device that greatly simplifies fluidic handling, increasing throughput by 20-fold and enables the use of low-volume samples26.”
From Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate (2016) · cites this paper as [26]
Single-cell mass and MAR can now be measured at over 60 cells per hour per device without losing precision.
“However, single-cell mass and MAR can now be obtained with a throughput exceeding 60 cells/hr/device without sacrificing precision26.”
From Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate (2016) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 41 · Cited by 227
Research works printed but not linked: 2
- [38]Stone HA CMOS Biotechnology Lee H Westervelt RM Ham D 5 30 Springer US 2007
- [45]Cleland AN Foundations of Nanomechanics: From Solid-State Theory to Device Applications Springer Science & Business Media 2013
- Authors
- Cermak, N., Olcum, S., Delgado, F. F., Wasserman, S. C., Payer, K. R., A Murakami, M., Knudsen, S. M., Kimmerling, R. J., Stevens, M. M., Kikuchi, Y., Sandikci, A., Ogawa, M., Agache, V., Baléras, F., Weinstock, D. M., & Manalis, S. R.
- Affiliations
- Massachusetts Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Innovative Micro Technology (United States) (US)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Broad Institute (US)
- Corresponding author
- Manalis, Scott R
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2016-09-05
- Volume
- 34
- Issue
- 10
- Pages
- 1052-1059
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC5064867
- OpenAlex
- W2518601669
- Cited by
- 227
- References
- 41
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 11 · 2023: 22 · 2022: 23 · 2021: 30 · 2020: 33 · 2019: 29 · 2018: 33 · 2017: 21 · 2016: 3
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Science Foundation (P30-CA14051, 1129359)
- Dana-Farber Cancer Institute
- Dana-Farber/Harvard Cancer Center
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (P30-CA14051)
- Institut Mérieux
- National Cancer Institute (U54CA143874, CA14051, DP1CA174420, T32CA009172, P30CA014051, R33CA191143, P30-CA-14051)
- National Institute of General Medical Sciences (T32GM087237, T32GM008334)
- National Institute of Allergy and Infectious Diseases (R21AI110787)
- Army Research Office (#W911NF-09-D-0001, W911NF)
- Institute for Collaborative Biotechnologies (W911NF‐09‐D‐0001)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Bio-sensing Technologies
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Physical Sciences › Engineering › Biomedical Engineering › Acoustic Wave Resonator Technologies
- Keywords
- resonant mass sensors, cell growth kinetics, high-throughput cell analysis, drug susceptibility testing, antibiotic treatment response, antimicrobial peptides, T cells, leukemia cells, yeast, Escherichia coli, Enterococcus faecalis, bacterial growth
- MeSH terms
- Drug Evaluation, Preclinical, Equipment Design, Sensitivity and Specificity, Transducers, Reproducibility of Results, Equipment Failure Analysis, Cell Proliferation, Micro-Electrical-Mechanical Systems, Lab-On-A-Chip Devices, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review